A phase II clinical study of RAIN-32 in intimal sarcoma
Latest Information Update: 26 Feb 2023
At a glance
- Drugs Milademetan (Primary)
- Indications Sarcoma
- Focus Therapeutic Use
- 29 Dec 2022 According to Rain Oncology media release, Rain Therapeutics has changed its name to Rain Oncology.
- 10 Aug 2021 According to a Rain Therapeutics media release, the company anticipates interim data in late 2022.
- 28 May 2021 New trial record